Document is current

Any future updates will be listed below

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

Crossref DOI link: https://doi.org/10.1186/s40425-017-0287-5

Published Online: 2017-10-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark